According to a new report from Intel Market Research, the global Benign Prostatic Hyperplasia Stent Market was valued at USD 1.30 billion in 2025 and is projected to reach USD 2.37 billion by 2034, growing at a CAGR of 7.0% during the forecast period (2026–2034). This expansion is propelled by an aging male demographic exceeding 900 million worldwide, rapid technological innovation such...